These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29133954)

  • 61. The corticosteroid prednisolone increases amygdala and insula reactivity to food approach signals in healthy young men.
    Serfling G; Buades-Rotger M; Harbeck B; Krämer UM; Brabant G
    Psychoneuroendocrinology; 2019 Jan; 99():154-165. PubMed ID: 30245328
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice.
    Faccidomo S; Swaim KS; Saunders BL; Santanam TS; Taylor SM; Kim M; Reid GT; Eastman VR; Hodge CW
    Psychopharmacology (Berl); 2018 Jun; 235(6):1681-1696. PubMed ID: 29502276
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving.
    Leggio L; Ferrulli A; Cardone S; Nesci A; Miceli A; Malandrino N; Capristo E; Canestrelli B; Monteleone P; Kenna GA; Swift RM; Addolorato G
    Addict Biol; 2012 Mar; 17(2):452-64. PubMed ID: 21392177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Laboratory alcohol self-administration experiments do not increase subsequent real-life drinking in young adult social drinkers.
    Sommer C; Seipt C; Spreer M; Blümke T; Markovic A; Jünger E; Plawecki MH; Zimmermann US
    Alcohol Clin Exp Res; 2015 Jun; 39(6):1057-63. PubMed ID: 25903217
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers.
    Sarid-Segal O; Knapp CM; Burch W; Richardson MA; Bahtia S; DeQuattro K; Afshar M; Richambault C; Sickels L; Devine E; Ciraulo DA
    Am J Drug Alcohol Abuse; 2009; 35(5):316-9. PubMed ID: 19637104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
    Sutera FM; De Caro V; Cannizzaro C; Giannola LI; Lavanco G; Plescia F
    Behav Brain Res; 2016 Sep; 310():109-18. PubMed ID: 27155501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The galanin-3 receptor antagonist, SNAP 37889, suppresses alcohol drinking and morphine self-administration in mice.
    Scheller KJ; Williams SJ; Lawrence AJ; Djouma E
    Neuropharmacology; 2017 May; 118():1-12. PubMed ID: 28274821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subjective responses to alcohol in the lab predict neural responses to alcohol cues.
    Courtney KE; Ray LA
    J Stud Alcohol Drugs; 2014 Jan; 75(1):124-35. PubMed ID: 24411804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced alcohol-drinking behavior associated with active ghrelinergic and serotoninergic neurons in the lateral hypothalamus and amygdala.
    Yoshimoto K; Nagao M; Watanabe Y; Yamaguchi T; Ueda S; Kitamura Y; Nishimura K; Inden M; Marunaka Y; Hattori H; Murakami K; Tokaji M; Ochi K
    Pharmacol Biochem Behav; 2017 Feb; 153():1-11. PubMed ID: 27940067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.
    Leão RM; Cruz FC; Vendruscolo LF; de Guglielmo G; Logrip ML; Planeta CS; Hope BT; Koob GF; George O
    J Neurosci; 2015 Apr; 35(15):6241-53. PubMed ID: 25878294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drinking water to reduce alcohol craving? A randomized controlled study on the impact of ghrelin in mediating the effects of forced water intake in alcohol addiction.
    Koopmann A; Lippmann K; Schuster R; Reinhard I; Bach P; Weil G; Rietschel M; Witt SH; Wiedemann K; Kiefer F
    Psychoneuroendocrinology; 2017 Nov; 85():56-62. PubMed ID: 28822300
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex Differences in Motivation to Self-Administer Alcohol After 2 Weeks of Abstinence in Young-Adult Heavy Drinkers.
    Plawecki MH; White K; Kosobud AEK; Grahame N; Zimmermann US; Crabb D; O'Connor S
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1897-1908. PubMed ID: 30080254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study.
    Farr OM; Tsoukas MA; Triantafyllou G; Dincer F; Filippaios A; Ko BJ; Mantzoros CS
    Metabolism; 2016 Jul; 65(7):945-53. PubMed ID: 27282865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol.
    Stoops WW; Strickland JC; Hays LR; Rayapati AO; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2020 Nov; 198():173037. PubMed ID: 32891709
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers.
    Lee MR; Farokhnia M; Cobbina E; Saravanakumar A; Li X; Battista JT; Farinelli LA; Akhlaghi F; Leggio L
    Neuropharmacology; 2020 Jun; 170():107788. PubMed ID: 31557492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
    van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
    Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.